Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Novartis
Daiichi Sankyo
Covington
Express Scripts
Merck
UBS
Citi
US Army
Moodys

Generated: January 23, 2018

DrugPatentWatch Database Preview

Methylprednisolone sodium succinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methylprednisolone sodium succinate and what is the scope of methylprednisolone sodium succinate patent protection?

Methylprednisolone sodium succinate
is the generic ingredient in four branded drugs marketed by Abbott, Hospira, Hospira Inc, Elkins Sinn, Organon Usa Inc, Abraxis Pharm, Amneal Pharms Co, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma Farmaceutica, Intl Medication, Sagent Pharms, Teva Parenteral, Watson Labs, and Pharmacia And Upjohn, and is included in forty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are forty drug master file entries for methylprednisolone sodium succinate. Ten suppliers are listed for this compound.
Pharmacology for methylprednisolone sodium succinate

US Patents and Regulatory Information for methylprednisolone sodium succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 207667-004 Dec 15, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040583-002 Jul 30, 2004 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn SOLU-MEDROL methylprednisolone sodium succinate INJECTABLE;INJECTION 011856-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Intl Medication METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 087851-001 Feb 9, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040583-001 Jul 30, 2004 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn SOLU-MEDROL methylprednisolone sodium succinate INJECTABLE;INJECTION 011856-007 Feb 27, 1985 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 089189-001 Mar 28, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbott A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 089575-001 Feb 22, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 207667-001 Dec 15, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 088678-001 Jun 8, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Johnson and Johnson
Moodys
Argus Health
Daiichi Sankyo
Citi
Covington
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot